
Our Leadership - FNIH
Dr. Stacey Adam is a Vice President at the FNIH, leading many public-private partnerships, such as Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV); the Biomarkers Consortium (Cancer and Metabolic Disorders Steering Committees) and their projects; Accelerating Medicines Partnerships (AMPs)-Common Metabolic Diseases, Heart Failure, and …
Groundbreaking Collaborative Clinical Trial Launched - FNIH
2014年6月13日 · Groundbreaking Collaborative Clinical Trial Launched The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, MD, June 13, 2014 — A unique public-private collaboration among the National Cancer Institute (NCI), part of the National …
Home | FNIH
From ideation to implementation, we align public and private organizations around a common cause to achieve breakthrough results. Our goal is to help all people to live longer, healthier lives.
FNIH Supports New NIH Study Seeking Biomarkers for Autism …
2015年7月13日 · FNIH Supports New NIH Study Seeking Biomarkers for Autism Spectrum Disorders BETHESDA, MD, July 13, 2015 – The Foundation for the National Institutes of Health (FNIH) announced today a public-private collaboration with the National Institute of Mental Health (NIMH), a component of the National Institutes of Health, and the Simons Foundation Autism …
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Post-Acute Sequelae of SARS-CoV-2 (PASC)/Long COVID Seminar Series Whitepaper
State Nonprofit Disclosures - FNIH
State Charitable Solicitation Disclosures Certain states require written disclosures for nonprofit organizations soliciting contributions. Individual state disclosures are below. Florida: A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE FLORIDA DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE WITHIN …
Board of Directors + Governance - FNIH
Dr. Steve Paul is a venture partner at Third Rock Ventures, a biotech investment firm. Dr. Paul was most recently the Chief Scientific Officer, President of Research and Development, and member of the board of directors at Karuna Therapeutics.
Point Estimates of Rates of ACM versus ACM+ Endpoints (Study Dori-09) ACM: All-cause mortality; nv: non-ventilated. ACM+: Mortality plus -ACM plus Toxic/Septic Shock Standardized MedDRA Query adverse events
Haynes et al., Sci. Transl. ed. 12, eabe0948 (2020) 4 November 2020 SCIENCE TRANSLATIONAL MEDICINE| REVIEW 1 of 12 CORONAVIRUS Prospects for a safe COVID-19 vaccine Barton F. Haynes1*, Lawrence Corey2, Prabhavathi Fernandes3, Peter B. Gilbert4, Peter J. Hotez5, Srinivas Rao6, Michael R. Santos7, Hanneke Schuitemaker8, Michael Watson9, …
FNIH Awards Ceremony
Watch the full awards ceremony . More Awards Ceremony highlights include: The Lurie Prize in Biomedical Sciences, which recognizes outstanding achievement by promising scientists aged 52 or younger.The 2024 recipient was Howard Y. Chang, MD, PhD.